Compare ABEO & AVBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ABEO | AVBC |
|---|---|---|
| Founded | 1974 | 1869 |
| Country | United States | United States |
| Employees | N/A | 241 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 307.5M | 364.7M |
| IPO Year | 2005 | N/A |
| Metric | ABEO | AVBC |
|---|---|---|
| Price | $5.49 | $18.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $20.00 | $18.00 |
| AVG Volume (30 Days) | ★ 1.0M | 39.0K |
| Earning Date | 05-13-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 0.98% |
| EPS Growth | ★ 165.16 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,998,000.00 | N/A |
| Revenue This Year | $1,024.31 | N/A |
| Revenue Next Year | $145.42 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 258.18 | N/A |
| 52 Week Low | $4.00 | $14.23 |
| 52 Week High | $7.54 | $21.43 |
| Indicator | ABEO | AVBC |
|---|---|---|
| Relative Strength Index (RSI) | 51.22 | 33.21 |
| Support Level | $5.24 | $18.39 |
| Resistance Level | $5.54 | $19.80 |
| Average True Range (ATR) | 0.27 | 0.59 |
| MACD | -0.04 | -0.22 |
| Stochastic Oscillator | 35.50 | 10.31 |
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.
Avidia Bancorp Inc business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in commercial and industrial loans, one-to four-family residential mortgage loans, and commercial real estate loans.